Revenue YoY
—
Operating Income YoY
+178.54%
Net Income YoY
-17.60%
Net Margin Δ
—
Net income bridge for Alto Neuroscience (ANRO) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: -$11.1M-17.60%
Profit bridge breakdown for Alto Neuroscience (ANRO) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | -$63.2M | — |
| Revenue | $0.00 | +0.0% |
| Cost of Revenue | -$114K | -1.0% |
| Operating Expenses | $125M | +1,123.0% |
| Other Income / Expense | -$136M | -1,222.0% |
| Income Tax | $0.00 | -0.0% |
| Net Loss | -$74.3M | — |
- Prior Net Income-$63.2M
- Revenue$0.00
- Cost of Revenue-$114K
- Operating Expenses$125M
- Other Income / Expense-$136M
- Income Tax$0.00
- Net Loss-$74.3M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.